Effect of Pasta on Blood Glucose Response in Normal Subjects
NCT ID: NCT01469312
Last Updated: 2011-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2010-04-30
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control arm consists of the traditional pasta.
modified pasta
50 grams carbohydrate as a single breakfast meal
Modified pasta
Dreamfields, Miracle Noodles
modified pasta
50 grams carbohydrate as a single breakfast meal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
modified pasta
50 grams carbohydrate as a single breakfast meal
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minneapolis Veterans Affairs Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frank Q. Nuttall, MD, PhD
Chief, Section of Endocrinology, Metabolism & Nutrition, Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Q Nuttall, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Minneapolis Veterans Affairs Medical Center
Mary C Gannon, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Minneapolis Veterans Affairs Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minneapolis VA Health Care System
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nuttall FQ, Schweim K, Hoover H, Gannon MC. Effect of the LoBAG30 diet on blood glucose control in people with type 2 diabetes. Br J Nutr. 2008 Mar;99(3):511-9. doi: 10.1017/S0007114507819155. Epub 2007 Sep 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4231
Identifier Type: -
Identifier Source: org_study_id